SMA News Today

Plans Advance for Biomarkers Panel to Assess Drug-induced Skeletal Muscle Injury

Plans Advance for Biomarkers Panel to Assess Drug-induced Skeletal Muscle Injury

SMA News Today’s multimedia associate, Price Wooldridge, discusses plans being advanced for a biomarkers panel to assess drug-induced skeletal muscle injury in SMA. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Duration: 5 min

Release Date:

Share part or all of the audio of this episode